Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |